Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.40 |
| ▸ | KLK7 | P49862 | 4/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28464028 | 0.83 | SCN9A (0.37) | KLK7POLBMAPTNPC1 | |
| SCHEMBL28467756 | 0.83 | MAPT (0.41) | KLK7POLBL3MBTL1MAPTTSHR | |
| SCHEMBL28467755 | 0.83 | MAPT (0.41) | KLK7POLBL3MBTL1MAPTTSHR | |
| SCHEMBL17822757 | 0.82 | TAAR1 (0.48) | MAPTKMT2ANPC1 | |
| SCHEMBL17822756 | 0.82 | TAAR1 (0.48) | MAPTKMT2ANPC1 | |
| SCHEMBL28470192 | 0.81 | POLB (0.36) | HKDC1KLK7POLBMAPTKMT2A | |
| SCHEMBL28470191 | 0.81 | POLB (0.36) | HKDC1KLK7POLBMAPTKMT2A | |
| SCHEMBL28457630 | 0.78 | KLK7 (0.53) | HKDC1KLK7POLBMAPTTSHR | |
| SCHEMBL29000412 | 0.78 | KLK7 (0.53) | HKDC1KLK7POLBMAPTTSHR | |
| SCHEMBL18245320 | 0.76 | MAPT (0.42) | MAPTKMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109963870-B | anti-B7-H3 antibodies and antibody drug conjugates | 艾伯维公司 | 2023-07-28 | — | — | CN | disclosed |
| CN-116284404-A | anti-B7-H3 antibodies and antibody drug conjugates | 艾伯维公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-116173232-A | anti-CD 98 antibodies and antibody drug conjugates | 艾伯维公司 | 2023-05-30 | — | — | CN | disclosed |
| CN-116059201-A | anti-EGFR antibody drug conjugates | 艾伯维公司 | 2023-05-05 | — | — | CN | disclosed |
| CN-116059394-A | anti-EGFR antibody drug conjugates | 艾伯维公司 | 2023-05-05 | — | — | CN | disclosed |
| CN-116059202-A | anti-EGFR antibody drug conjugates | 艾伯维公司 | 2023-05-05 | — | — | CN | disclosed |
| CN-109562170-B | anti-CD 98 antibodies and antibody drug conjugates | 艾伯维公司（US） | 2023-01-13 | — | — | CN | disclosed |